New Insights into PAD2 Enzyme's Role in Pancreatic Cancer Progression
Scientists have identified the enzyme PAD2 as a crucial factor in pancreatic cancer growth, suggesting that targeting PAD2 could lead to new epigenetic treatments for PDAC.
Recent research conducted by scientists at the Institute of Science Tokyo has unveiled the significant role of the enzyme peptidyl-arginine deiminase 2 (PAD2) in the development and progression of pancreatic ductal adenocarcinoma (PDAC). Using advanced genetic manipulation techniques on pancreatic cancer cell lines and mouse models, researchers demonstrated that PAD2 facilitates tumor growth by promoting histone citrullination — a chemical modification of histone proteins that enhances gene expression. Their studies showed that increased PAD2 activity correlates with elevated expression of the PRUNE1 gene, which is associated with heightened cell proliferation and alteration of the tumor microenvironment.
The team’s immunohistochemistry analysis of patient tissue samples revealed that histone citrullination is more prevalent in PDAC tissues compared to normal pancreatic tissue and is linked to poorer overall survival rates. Manipulating PAD2 levels in cancer cells confirmed that overexpression of PAD2 accelerated cell proliferation, while its knockdown reduced tumor cell growth. In vivo experiments further substantiated these findings, as tumors derived from PAD2-overexpressing cells exhibited increased growth and immune cell infiltration, notably an influx of tumor-promoting M2 macrophages.
Crucially, treatment with PAD inhibitors, including Cl-amidine (a general PAD inhibitor) and AFM-30a (a PAD2-specific inhibitor), lowered PRUNE1 expression and significantly hindered tumor development in mouse models. These promising results suggest that targeting PAD2 enzymatic activity could serve as a potential strategy for epigenetic therapy in pancreatic cancer. Overall, this study highlights PAD2 as a key driver of PDAC progression and offers new avenues for therapeutic intervention.
Source: https://medicalxpress.com/news/2025-08-pad2-enzyme-key-driver-pancreatic.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Empowering Children with Autism Through Self-Directed Therapy Interventions
A new study demonstrates that including children with autism in their therapy planning improves goal achievement and promotes independence, leveraging telehealth for convenient, inclusive intervention.
How Dying Cancer Cells Reprogram Immune Cells to Support Tumor Growth
New research uncovers how dying cancer cells manipulate immune cells to produce signals that promote tumor growth, revealing potential targets for innovative treatments.
New Discoveries Reveal Diverse Roles of Proteins in Brain Communication
New research uncovers the multifaceted roles of α2δ proteins in brain signaling, with implications for neurological disorder treatments.
MRI Technique Enhances Identification of High-Risk Cardiac Sarcoidosis Patients for Implantable Defibrillators
Innovative MRI-based imaging techniques are improving the identification of cardiac sarcoidosis patients at high risk of sudden death, promoting targeted ICD therapy for better outcomes.